Ridgeline is Versant’s newest discovery engine and has laboratories in Basel Technology Park. Ridgeline’s leadership team hails from Roche and has a proven track record in drug development.
Highline Therapeutics focuses on accessing discovery technologies from New York City and Northeast academics.
Blueline Bioscience works closely with leading academic and medical research centers in Canada to develop, fund, and grow early-stage biotechnology companies.
Inception Sciences is a drug discovery incubator that is based on a proven team of drug developers. It is the parent company of Inception I and II.